文献速递乳腺US乳腺X线

双年度超声监测能否发现更小的第二原发癌或更早发现乳腺癌病史患者的癌症

Can Biannual Ultrasound Surveillance Detect Smaller Second Cancers or Detect Cancers Earlier in Patients with Breast Cancer History?
PubMed 文献 · Ultrasound Med Biol · 2018-04-10

该回顾性研究纳入3023例乳腺癌术后接受乳腺X线和超声监测的患者,比较双年度超声加年度乳腺X线(双年度组)与年度超声加乳腺X线(年度组)对第二原发癌的检出效果;结果显示两组第二原发癌大小无差异(12.8±6.6 mm vs 14.1±7.1 mm,p=0.461),有症状比例无显著差异(17.0%[8/47] vs 10%[2/20],p=0.711),远处转移患病率无差异(1.1%[27/2370] vs 1.0%[7/653],p=0.88);作者认为双年度超声监测未发现更小或更早的第二原发癌,但需随机对照研究验证。

要点

  • 双年度与年度超声监测检出的第二原发癌大小无差异(12.8±6.6 mm vs 14.1±7.1 mm,p=0.461)。
  • 两组诊断时存在症状的比例无显著差异(17.0%[8/47] vs 10%[2/20],p=0.711)。
  • 两组远处转移患病率无差异(1.1%[27/2370] vs 1.0%[7/653],p=0.88)。

核心结论

  • 回顾性研究结果表明,乳腺癌术后患者经双年度超声监测检出的第二原发癌并不比年度超声监测更小,也未更早发生;但需随机对照研究验证这些结果后才能推广至临床实践。

研究设计与样本

  • 回顾性研究,纳入2011年1月至2012年12月间3023例乳腺癌术后接受乳腺X线和超声监测随访的患者,按平均监测间隔分为双年度组和年度组,比较临床病理特征,并采用倾向评分法的多变量逻辑回归分析监测类型对结局的影响。

诊断标准与关键数值

  • 第二原发癌大小:双年度组12.8±6.6 mm vs 年度组14.1±7.1 mm,p=0.461。
  • 诊断时存在症状:双年度组17.0%(8/47)vs 年度组10%(2/20),p=0.711。
  • 远处转移患病率:双年度组1.1%(27/2370)vs 年度组1.0%(7/653),p=0.88,单变量和多变量分析均无差异。

临床应用与阅片要点

  • 作者认为,双年度超声监测检出的第二原发癌并不比年度超声监测更小或更早,但需随机对照研究验证这些结果后才能推广至临床实践。

局限性

  • 原文为回顾性研究。
  • 作者指出需随机对照研究验证这些结果后才能推广至临床实践。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

The aim of the work described here was to evaluate whether surveillance with biannual ultrasound (US) plus annual mammography (biannual group) for women with a history of breast cancer surgery results in earlier detection or in the detection of smaller second cancers than annual US plus mammography (annual group). Additionally, we compared the prevalence of distant metastases or palpable second cancers between the biannual and annual groups. The institutional review board of our institution approved this retrospective study, and patient consent was waived. Between January 2011 and December 2012, we retrospectively reviewed the clinical and imaging follow-up of 3023 patients with mammographic and US surveillance after breast cancer surgery to assess second cancers detected by local surveillance (locoregional recurrence, contralateral breast cancer or distant metastasis). The biannual and annual groups were divided with respect to the mean surveillance interval and compared with respect to clinicopathologic findings. Multivariable logistic regression with propensity score methods was used to examine the effect of the type of surveillance on outcomes. As for the size of the second cancer, no difference was seen between the biannual and annual groups (12.8 ± 6.6 mm vs. 14.1 ± 7.1 mm, p = 0.461); neither was there a significant difference between the groups in the presence of symptoms at the time of diagnosis of the second cancer (17.0% [8/47] vs. 10% [2/20], p = 0.711). Regardless of detection by local surveillance, the prevalence of distant metastases did not differ between the two groups (1.1% [27/2370] vs. 1.0% [7/653], p = 0.88) on univariate or multivariate analysis. The results of our retrospective study indicate that second cancers detected by biannual US surveillance in patients with a history of breast cancer surgery are not smaller and do not occur earlier than those detected by annual US surveillance. However, a randomized controlled study is required to verify these results before they can be generalized to clinical practice.

来源:Ultrasound Med Biol,查看原文。版权归原作者所有。

引用

  1. You JK, Song MK, Kim MJ, et al. Can Biannual Ultrasound Surveillance Detect Smaller Second Cancers or Detect Cancers Earlier in Patients with Breast Cancer History? Ultrasound Med Biol. 2018. PMID: 29653773. doi:10.1016/j.ultrasmedbio.2018.02.019

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。